These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 63321)
1. Radioimmunoassay of neocarzinostatin, an antitumor protein. Samy TS; Raso V Cancer Res; 1976 Dec; 36(12):4378-81. PubMed ID: 63321 [TBL] [Abstract][Full Text] [Related]
2. Enzyme immunoassay for pepleomycin, a new bleomycin analog. Fujiwara K; Yasuno M; Kitagawa T Cancer Res; 1981 Oct; 41(10):4121-6. PubMed ID: 6169433 [TBL] [Abstract][Full Text] [Related]
3. Enzyme immunoassay of neocarzinostatin using beta-galactosidase as label. Tanimori H; Kitagawa T; Tsunoda T; Tsuchiya R J Pharmacobiodyn; 1981 Oct; 4(10):812-9. PubMed ID: 6459444 [TBL] [Abstract][Full Text] [Related]
4. Radioimmunoassays for methotrexate, citrovorum factor, neocarzinostatin, and actinomycin D. Raso V Cancer Treat Rep; 1977 Jul; 61(4):585-90. PubMed ID: 141980 [TBL] [Abstract][Full Text] [Related]
5. Enzyme immunoassay with high sensitivity and accuracy for specific antibody to neocarzinostatin. Kitagawa T; Tanimori H; Yoshida K J Immunol Methods; 1984 Aug; 72(1):297-303. PubMed ID: 6235292 [TBL] [Abstract][Full Text] [Related]
6. Assay of an antitumor protein, neocarzinostatin, and its antibody by fluorescence polarization. Maeda H Clin Chem; 1978 Dec; 24(12):2139-44. PubMed ID: 152680 [TBL] [Abstract][Full Text] [Related]
7. Experimental and clinical studies on the formation of antibodies to neocarzinostatin, a new protein antibiotic. Sakamoto S; Maeda H; Matsumoto T; Ogata J Cancer Treat Rep; 1978 Dec; 62(12):2063-70. PubMed ID: 156066 [TBL] [Abstract][Full Text] [Related]
8. Radioimmune assay and characteristics of antibodies to macromomycin (NSC 170105). Winkelhake JL; Buckmire FL Cancer Res; 1977 Apr; 37(4):1197-204. PubMed ID: 844045 [TBL] [Abstract][Full Text] [Related]
9. An antitumor polypeptide antibiotic neocarzinostatin: the mode of apo-protein--chromophore interaction. Edo K; Saito K; Akiyama-Murai Y; Mizugaki M; Koide Y; Ishida N J Antibiot (Tokyo); 1988 Apr; 41(4):554-62. PubMed ID: 2967272 [TBL] [Abstract][Full Text] [Related]
10. Absence of anti-neocarzinostatin (NCS) antibody production in leukemia patients treated with NCS. Toki H Acta Med Okayama; 1976 Apr; 30(2):135-42. PubMed ID: 135485 [TBL] [Abstract][Full Text] [Related]
11. A radioactive hapten-binding assay for measuring antibodies to the pentapeptide determinant of peptidoglycan. Heymer B; Bernstein D; Schleifer KH; Krause RM J Immunol; 1975 Apr; 114(4):1191-6. PubMed ID: 46893 [TBL] [Abstract][Full Text] [Related]
12. In vivo antitumor activity of neocarzinostatin (NCS)-tumor antibody conjugate against a transplantable human leukemia cell line (BALL-1). Kimura I; Tsubota T; Ohnoshi T; Sato Y; Okazaki M; Manabe Y; Abe S Jpn J Clin Oncol; 1983 Jun; 13(2):425-33. PubMed ID: 6224954 [TBL] [Abstract][Full Text] [Related]
13. [Immunoresponses and efficacy after arterial infusion of immunoconjugate A7-NCS in patients with colon cancer]. Honda M; Yamaguchi T; Ohtsuji E; Noguchi A; Chimori Y; Doi M; Kamiguchi M; Noguchi A; Kitamura K; Yokota T Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 2):1811-4. PubMed ID: 2143891 [TBL] [Abstract][Full Text] [Related]
14. Additive effects of bleomycin and neocarzinostatin on degradation of DNA, inhibition of DNA polymerase beta, and cell growth. Müller WE; Maidhof A; Arendes J; Geurtsen W; Zahn RK; Schmidseder R Cancer Res; 1979 Sep; 39(9):3768-73. PubMed ID: 89904 [TBL] [Abstract][Full Text] [Related]
15. Applicability of monoclonal antibody Fab fragments as a carrier of neocarzinostatin in targeting chemotherapy. Otsuji E; Yamaguchi T; Tsuruta H; Yata Y; Nishi H; Okamoto K; Taniguchi K; Kato M; Kotani T; Kitamura K; Takahashi T J Surg Oncol; 1996 Feb; 61(2):149-54. PubMed ID: 8606548 [TBL] [Abstract][Full Text] [Related]
16. Radioimmunoassay of calcitonin in unextracted human serum: a sensitive method. Emmertsen K; Marqversen J; Jensen FT; Hansen HH Scand J Clin Lab Invest; 1982 Nov; 42(7):539-44. PubMed ID: 6186008 [TBL] [Abstract][Full Text] [Related]
17. [Clinical application of monoclonal antibody-drug conjugates in colorectal carcinoma]. Takahashi T; Sakita M; Yamaguchi T; Kitamura K; Hata K; Noguchi A Gan To Kagaku Ryoho; 1988 May; 15(5):1702-9. PubMed ID: 2967049 [TBL] [Abstract][Full Text] [Related]
18. Spontaneous deamidation of a protein antibiotic, neocarzinostatin, at weakly acidic pH. Conversion to a homologous inactive preneocarzinostatin due to change of asparagine 83 to aspartic acid 83 accompanied by conformational and biological alterations. Maeda H; Kuromizu K J Biochem; 1977 Jan; 81(1):25-35. PubMed ID: 14934 [TBL] [Abstract][Full Text] [Related]
19. A facile method of purification of neocarzinostatin, an antitumor protein. Samy TS; Hu JM; Meienhofer J; Lazarus H; Johnson RK J Natl Cancer Inst; 1977 Jun; 58(6):1765-8. PubMed ID: 140942 [TBL] [Abstract][Full Text] [Related]
20. Isolation of a non-protein component and a protein component from neocarzinostatin (NCS) and their biological activities. Koide Y; Ishii F; Hasuda K; Koyama Y; Edo K; Kitamine S; Kitame F; Ishida N J Antibiot (Tokyo); 1980 Mar; 33(3):342-6. PubMed ID: 6445889 [No Abstract] [Full Text] [Related] [Next] [New Search]